Dextech Medical AB (XSAT:DEX)
Sweden
· Delayed Price · Currency is SEK 10.80
+0.50 (4.85%)
At close: Mar 6, 2026
Dextech Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is July - June.
Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 12.21 | 14.71 | 19.04 | 25.24 | 35.47 | 3.46 | Upgrade
|
| Cash & Short-Term Investments | 12.21 | 14.71 | 19.04 | 25.24 | 35.47 | 3.46 | Upgrade
|
| Cash Growth | -25.18% | -22.76% | -24.54% | -28.86% | 926.20% | -43.25% | Upgrade
|
| Other Receivables | - | 0.09 | 0.13 | 0.11 | 0.2 | 0.03 | Upgrade
|
| Receivables | 0.47 | 0.09 | 0.13 | 0.11 | 0.2 | 0.03 | Upgrade
|
| Other Current Assets | - | 0.38 | 0.5 | 0.47 | 0.35 | 0.26 | Upgrade
|
| Total Current Assets | 12.68 | 15.18 | 19.68 | 25.82 | 36.02 | 3.75 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Intangible Assets | 9.64 | 0.25 | 0.25 | 0.25 | 0.39 | 0.54 | Upgrade
|
| Long-Term Deferred Charges | - | 9.67 | 10.66 | 8.97 | 3.18 | 2.94 | Upgrade
|
| Total Assets | 22.32 | 25.1 | 30.59 | 35.03 | 39.59 | 7.23 | Upgrade
|
| Accounts Payable | - | 0.13 | 0.28 | 0.15 | 0.25 | 0.04 | Upgrade
|
| Accrued Expenses | - | 0.18 | 0.69 | 0.55 | 0.43 | 0.15 | Upgrade
|
| Other Current Liabilities | 0.44 | 0.02 | 0.01 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Total Current Liabilities | 0.44 | 0.34 | 0.98 | 0.72 | 0.71 | 0.22 | Upgrade
|
| Total Liabilities | 0.44 | 0.34 | 0.98 | 0.72 | 0.71 | 0.22 | Upgrade
|
| Common Stock | 21.88 | 0.83 | 0.83 | 0.83 | 0.83 | 0.67 | Upgrade
|
| Additional Paid-In Capital | - | 105.2 | 105.2 | 105.2 | 105.2 | 68.22 | Upgrade
|
| Retained Earnings | - | -81.26 | -76.42 | -71.71 | -67.15 | -61.88 | Upgrade
|
| Shareholders' Equity | 21.88 | 24.76 | 29.61 | 34.31 | 38.88 | 7.02 | Upgrade
|
| Total Liabilities & Equity | 22.32 | 25.1 | 30.59 | 35.03 | 39.59 | 7.23 | Upgrade
|
| Net Cash (Debt) | 12.21 | 14.71 | 19.04 | 25.24 | 35.47 | 3.46 | Upgrade
|
| Net Cash Growth | -25.18% | -22.76% | -24.54% | -28.86% | 926.20% | -43.25% | Upgrade
|
| Net Cash Per Share | 0.66 | 0.79 | 1.01 | 1.37 | 2.09 | 0.23 | Upgrade
|
| Filing Date Shares Outstanding | 18.49 | 18.49 | 18.49 | 18.49 | 18.49 | 14.92 | Upgrade
|
| Total Common Shares Outstanding | 18.49 | 18.49 | 18.49 | 18.49 | 18.49 | 14.92 | Upgrade
|
| Working Capital | 12.24 | 14.85 | 18.7 | 25.1 | 35.31 | 3.54 | Upgrade
|
| Book Value Per Share | 1.18 | 1.34 | 1.60 | 1.86 | 2.10 | 0.47 | Upgrade
|
| Tangible Book Value | 12.24 | 24.51 | 29.36 | 34.07 | 38.49 | 6.47 | Upgrade
|
| Tangible Book Value Per Share | 0.66 | 1.33 | 1.59 | 1.84 | 2.08 | 0.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.